Medications

Proof of added benefit of apixaban in hip replacement

The clot-inhibiting drug apixaban (trade name: Eliquis) was approved in May 2011 for the prevention of thrombosis (blood clots) after operations to replace a hip or knee joint. In an early benefit assessment pursuant to the ...

Health

English hospitals can improve their performance

NHS hospitals have substantial scope to improve their efficiency by adopting best practice, according to research published today by Professor Andrew Street and colleagues at the Centre for Health Economics (CHE) at the University ...

Other

Hip implant for long-term use

Hip replacement is one of the most frequent operations carried out in Germany. Each year, doctors implant some 200,000 artificial hip joints. Often the artificial hips need to be replaced just ten years later. In the future, ...

Other

Artificial hips find some sports wearing

A growing number of patients want to return to sport, and in some cases high-impact sports like jogging and soccer, after total hip replacement (or arthroplasty) operations. Although many surgeons already recommend certain ...

Other

Lifelong checks for metal hip implant patients

The UK government's health regulator has advised new checks for patients who have undergone large head metal-on-metal hip replacements, following a major investigation by Newcastle University engineers.

page 20 from 24